ftInvstr

PPLPHARMA · Healthcare ₹213.96 -0.14% Mkt Cap ₹28401 Cr overvalued

PPLPHARMA

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹213.96

-0.14% today · 30d +2.88%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for PPLPHARMA. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-06-30

REVENUE

₹2270 Cr

+17.39% YoY

NET PROFIT

₹-69 Cr

OPM

12.06%

+3.78pp YoY

EPS

₹-0.52

Intrinsic value · DCF ₹90.41 · Margin of safety -57.7% (overvalued) · FCF yield 2.69%

◇ Sector Position

PEERPEROCE %

PPLPHARMA—3.0

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance STRONG 75

Valuation — —

Growth MUTED 37

Profitability AVERAGE 42

Technicals NEUTRAL 67

Risk LOW 70

Key Stats

P/B

3.57

52W HIGH

₹220.36

OFF HIGH

-2.9%

DIV YIELD

0.08%

MKT CAP

₹28401 Cr

◉ Active Signals

MACDNeutral-1.0665

RSI(14)Neutral59.38

Near 52W HighBullish-2.9

Street Consensus

11 analysts

₹233.27

mean target

Low ₹200.0Now ₹213.96High ₹265.0

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold PPLPHARMA and at what entry.